Literature DB >> 11543623

Arterial identity of endothelial cells is controlled by local cues.

K Othman-Hassan1, K Patel, M Papoutsi, M Rodriguez-Niedenführ, B Christ, J Wilting.   

Abstract

The ephrins and their Eph receptors comprise the largest family of receptor tyrosine kinases. Studies on mice have revealed an important function of ephrin-B2 and Eph-B4 for the development of the arterial and venous vasculature, respectively, but the mechanisms regulating their expression have not been studied yet. We have cloned a chick ephrin-B2 cDNA probe. Expression was observed in endothelial cells of extra- and intraembryonic arteries and arterioles in all embryos studied from day 2 (stage 10 HH, before perfusion of the vessels) to day 16. Additionally, expression was found in the somites and neural tube in early stages, and later also in the smooth muscle cells of the aorta, parts of the Müllerian duct, dosal neural tube, and joints of the limbs. We isolated endothelial cells from the internal carotid artery and the vena cava of 14-day-old quail embryos and grafted them separately into day-3 chick embryos. Reincubation was performed until day 6 and the quail endothelial cells were identified with the QH1 antibody. The grafted arterial and venous endothelial cells expressed ephrin-B2 when they integrated into the lining of arteries. Cells that were not integrated into vessels, or into vessels other than arteries, were ephrin-B2-negative. The studies show that the expression of the arterial marker ephrin-B2 is controlled by local cues in arterial vessels of older embryos. Physical forces or the media smooth muscle cells may be involved in this process. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11543623     DOI: 10.1006/dbio.2001.0383

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  25 in total

Review 1.  Molecular control of arterial-venous blood vessel identity.

Authors:  Ralf H Adams
Journal:  J Anat       Date:  2003-01       Impact factor: 2.610

Review 2.  Cellular and molecular mechanisms of embryonic haemangiogenesis and lymphangiogenesis.

Authors:  Jörg Wilting; Bodo Christ; Li Yuan; Anne Eichmann
Journal:  Naturwissenschaften       Date:  2003-09-17

Review 3.  Eph/ephrin molecules--a hub for signaling and endocytosis.

Authors:  Mara E Pitulescu; Ralf H Adams
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

4.  Altered vascular expression of EphrinB2 and EphB4 in a model of oxygen-induced retinopathy.

Authors:  Michael H Davies; Andrew J Stempel; Kristin E Hubert; Michael R Powers
Journal:  Dev Dyn       Date:  2010-06       Impact factor: 3.780

5.  Coronary arteries form by developmental reprogramming of venous cells.

Authors:  Kristy Red-Horse; Hiroo Ueno; Irving L Weissman; Mark A Krasnow
Journal:  Nature       Date:  2010-03-25       Impact factor: 49.962

Review 6.  Genetic and epigenetic mechanisms in the early development of the vascular system.

Authors:  Domenico Ribatti
Journal:  J Anat       Date:  2006-02       Impact factor: 2.610

Review 7.  Vascular development in the zebrafish.

Authors:  Aniket V Gore; Kathryn Monzo; Young R Cha; Weijun Pan; Brant M Weinstein
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

8.  Engineered microvessels with strong alignment and high lumen density via cell-induced fibrin gel compaction and interstitial flow.

Authors:  Kristen T Morin; Jessica L Dries-Devlin; Robert T Tranquillo
Journal:  Tissue Eng Part A       Date:  2013-11-14       Impact factor: 3.845

9.  Pericyte Ontogeny: The Use of Chimeras to Track a Cell Lineage of Diverse Germ Line Origins.

Authors:  Heather C Etchevers
Journal:  Methods Mol Biol       Date:  2021

10.  Notch signaling regulates venous arterialization during zebrafish fin regeneration.

Authors:  Yoshiko Kametani; Neil C Chi; Didier Y R Stainier; Shinji Takada
Journal:  Genes Cells       Date:  2015-03-25       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.